Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Heparin in Severe Sepsis with Suspected DIC
NCT02654561Phase 3Unknown
- Sponsor
- China Medical University
- Start
- Apr 2018
- Primary completion
- Dec 2024
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of heparin in sepsis, disseminated intravascular coagulation (DIC), sponsored by China Medical University. Status: unknown.
02
Drugs
heparin
03
Conditions
sepsisdisseminated intravascular coagulation (DIC)
Beyond the preview
Go deeper on NCT02654561.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02654561.